These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8545811)

  • 21. Clonidine provides an allergy-free alternative in glaucoma patients with proven allergy to apraclonidine.
    Geyer O; Schmidt KG; Pianka P; Neudorfer M; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):149-52. PubMed ID: 10766284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apraclonidine and argon laser trabeculoplasty.
    Ofner S; Samples JR; van Buskirk EM
    Am J Ophthalmol; 1992 Dec; 114(6):778-9. PubMed ID: 1361104
    [No Abstract]   [Full Text] [Related]  

  • 23. New medical therapies for glaucoma.
    Drake MV
    Int Ophthalmol Clin; 1996; 36(2):53-60. PubMed ID: 8950633
    [No Abstract]   [Full Text] [Related]  

  • 24. Apraclonidine and argon laser trabeculoplasty.
    Holmwood PC; Chase RD; Krupin T; Rosenberg LF; Ruderman JM; Tallman BA; Brodstein DE; Chopra H; Goldenfeld M
    Am J Ophthalmol; 1992 Jul; 114(1):19-22. PubMed ID: 1352428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of apraclonidine on short-term outcome of glaucoma surgery.
    Azuara-Blanco A; Araujo SV; Lu DW; Lesk MR; Katz LJ; Spaeth GL
    J Glaucoma; 1996 Apr; 5(2):117-9. PubMed ID: 8795743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of apraclonidine in long-term timolol users.
    Gharagozloo NZ; Brubaker RF
    Ophthalmology; 1991 Oct; 98(10):1543-6. PubMed ID: 1683697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma.
    Sebastiani A; Parmeggiani F; Costagliola C; Ciancaglini M; D'Oronzo E; Mastropasqua L
    Acta Ophthalmol Scand Suppl; 2002; 236():29-30. PubMed ID: 12390124
    [No Abstract]   [Full Text] [Related]  

  • 29. Selectivity of site of action and systemic effects of topical alpha agonists.
    Robin AL; Burnstein Y
    Curr Opin Ophthalmol; 1998 Apr; 9(2):30-3. PubMed ID: 10180510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of apraclonidine to prevent delayed IOP elevation after Nd:YAG laser posterior capsulotomy.
    Nesher R; Kolker AE
    Trans Am Ophthalmol Soc; 1990; 88():229-32; discussion 233-6. PubMed ID: 1982748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect and side effects of apraclonidine].
    Stewart WC
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):A7-13. PubMed ID: 8965469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
    Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
    Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
    Barnes SD; Campagna JA; Dirks MS; Doe EA
    Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
    Allf BE; Shields MB
    Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
    Gebhardt DO
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):275. PubMed ID: 10086159
    [No Abstract]   [Full Text] [Related]  

  • 36. Additive effect of 1% apraclonidine hydrochloride to nonselective beta-blockers.
    Yaldo MK; Shin DH; Parrow KA; Lee SH; Lee SY
    Ophthalmology; 1991 Jul; 98(7):1075-8. PubMed ID: 1679916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergic contact dermatitis from apraclonidine in eyedrops.
    Silvestre JF; Carnero L; Ramón R; Albares MP; Botella R
    Contact Dermatitis; 2001 Oct; 45(4):251. PubMed ID: 11683848
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of apraclonidine hydrochloride on the attack of Posner-Schlossman syndrome.
    Hong C; Song KY
    Korean J Ophthalmol; 1993 Jun; 7(1):28-33. PubMed ID: 7901442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of brimonidine in the treatment of open-angle glaucoma.
    Wilensky JT
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S3-7. PubMed ID: 8970244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.